JP2006505556A - 過敏症の治療 - Google Patents

過敏症の治療 Download PDF

Info

Publication number
JP2006505556A
JP2006505556A JP2004543827A JP2004543827A JP2006505556A JP 2006505556 A JP2006505556 A JP 2006505556A JP 2004543827 A JP2004543827 A JP 2004543827A JP 2004543827 A JP2004543827 A JP 2004543827A JP 2006505556 A JP2006505556 A JP 2006505556A
Authority
JP
Japan
Prior art keywords
side chain
hypersensitivity
treatment
compound
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004543827A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006505556A5 (enExample
Inventor
イアン・アレキサンダー・シールズ
スティーブン・マックスウェル・テイラー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Queensland
Original Assignee
University of Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Queensland filed Critical University of Queensland
Publication of JP2006505556A publication Critical patent/JP2006505556A/ja
Publication of JP2006505556A5 publication Critical patent/JP2006505556A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2004543827A 2002-10-17 2003-10-16 過敏症の治療 Pending JP2006505556A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002952129A AU2002952129A0 (en) 2002-10-17 2002-10-17 Treatment of hypersensitivity conditions
PCT/AU2003/001374 WO2004035080A1 (en) 2002-10-17 2003-10-16 Treatment of hypersensitivity conditions

Publications (2)

Publication Number Publication Date
JP2006505556A true JP2006505556A (ja) 2006-02-16
JP2006505556A5 JP2006505556A5 (enExample) 2006-11-24

Family

ID=28047696

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004543827A Pending JP2006505556A (ja) 2002-10-17 2003-10-16 過敏症の治療

Country Status (6)

Country Link
US (1) US20070021329A1 (enExample)
EP (1) EP1560592A4 (enExample)
JP (1) JP2006505556A (enExample)
AU (1) AU2002952129A0 (enExample)
CA (1) CA2542510A1 (enExample)
WO (1) WO2004035080A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016104738A1 (ja) * 2014-12-26 2016-06-30 三菱レイヨン株式会社 ヒト以外の哺乳動物の皮膚疾患を治療する方法及び治療装置

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS160602A0 (en) * 2002-04-08 2002-05-16 University Of Queensland, The Therapeutic method
AU2002952086A0 (en) * 2002-10-16 2002-11-07 The University Of Queensland Treatment of osteoarthritis
AU2003902586A0 (en) * 2003-05-26 2003-06-12 The University Of Queensland Treatment of burns
GB2477831B (en) * 2008-09-18 2013-03-27 Micromass Ltd Ion guide array
WO2010065671A2 (en) * 2008-12-04 2010-06-10 Curna, Inc. Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002508767A (ja) * 1997-06-25 2002-03-19 ザ・ユニバーシティ・オブ・クイーンズランド Ｃ５ａ受容体およびＧタンパク質結合受容体の環状アゴニストおよびアンタゴニスト

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020107197A1 (en) * 2000-09-20 2002-08-08 Yan Xu Ligands for G protein coupled receptors and methods of using them
AUPR833401A0 (en) * 2001-10-17 2001-11-08 University Of Queensland, The G protein-coupled receptor antagonists

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002508767A (ja) * 1997-06-25 2002-03-19 ザ・ユニバーシティ・オブ・クイーンズランド Ｃ５ａ受容体およびＧタンパク質結合受容体の環状アゴニストおよびアンタゴニスト

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016104738A1 (ja) * 2014-12-26 2016-06-30 三菱レイヨン株式会社 ヒト以外の哺乳動物の皮膚疾患を治療する方法及び治療装置
JPWO2016104738A1 (ja) * 2014-12-26 2017-04-27 三菱レイヨン株式会社 ヒト以外の哺乳動物の皮膚疾患を治療する方法及び治療装置

Also Published As

Publication number Publication date
WO2004035080A1 (en) 2004-04-29
AU2002952129A0 (en) 2002-10-31
EP1560592A1 (en) 2005-08-10
EP1560592A4 (en) 2010-03-03
CA2542510A1 (en) 2004-04-29
US20070021329A1 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
EA018007B1 (ru) Композиция, содержащая орнитин и фенилацетат или фенилбутират, для лечения печеночной энцефалопатии
KR102222619B1 (ko) Rxr 작용제 및 갑상선 호르몬의 조합을 사용한 자가면역 질환의 치료
EA200601799A1 (ru) Гидразидсодержащие соединения - ингибиторы cftr и их применение
EA021303B1 (ru) Способы лечения или профилактики рвоты с помощью агентов, усиливающих секрецию гормона роста
US20090004264A1 (en) Methods for treating and ameliorating the symptons of inflammatory bowel diseases
US20100267639A1 (en) Treatment of osteoarthritis
US20250152665A1 (en) Mutant Peptides And Methods Of Treating Subjects Using The Same
JP2017128578A (ja) 腎疾患の治療におけるモノおよびジカルボン酸のアミドの使用
KR20070036033A (ko) 보체 Ｃ５ａ 수용체 조절제를 이용한 신경계 증상의치료방법
US20070021329A1 (en) Treatment of hypersensitivity conditions
Pelc et al. The structure and function of the epidermal barrier in patients with atopic dermatitis–treatment options. Part two
AU2003266862B2 (en) Treatment of hypersensitivity conditions
US20180085460A1 (en) Methods of treating prostatitis
AU2003266862A1 (en) Treatment of hypersensitivity conditions
TW202340233A (zh) 肽用於治療神經退行性疾病或改善認知功能的用途
JP4253161B2 (ja) アレルギー性疾患治療用外用剤
US20070054841A1 (en) Method of treatment of systemic injury secondary to burns
Konno et al. Effect of Azelastine on Endotoxin-lnduced Airway Hyperresponsiveness in Mice
KR20250094840A (ko) 사이클로-히스프로 유도체 및 이를 포함하는 섬유증의 예방, 개선 또는 치료용 조성물
JP2025505538A (ja) アレルギー性喘息の治療および／または予防のためのスーパーオキシドジスムターゼの使用
AU2004241673A1 (en) Method of treatment of systemic injury secondary to burns

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060929

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060929

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091117

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100217

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100224

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100907